进博会坚定跨国企业在华发展信心

Group 1 - The 8th China International Import Expo concluded with a record intended transaction amount of 83.49 billion USD, marking a 4.4% increase from the previous event [1] - Many exhibitors expressed strengthened confidence in developing their businesses in China, aiming to contribute to the high-quality development of the Chinese economy [1] - Sanofi's Greater China President highlighted the power of "openness" experienced at the expo, emphasizing new partnerships and projects that could enhance healthcare in China [1] Group 2 - AstraZeneca's China General Manager noted the company's commitment to transforming exhibits into products, showcasing significant investments and collaborations at the expo [2] - AstraZeneca presented two innovative cancer drugs for their first exhibition in China, reflecting their dedication to scientific innovation and sustainable development [2] - APP's Vice President emphasized the expo as a vital platform for high-level openness and the company's focus on high-quality development and industry collaboration [2] Group 3 - Bayer showcased 26 innovative products and secured over 10 strategic agreements during the expo, participating in more than 50 activities [3] - Bayer's global executive vice president expressed satisfaction with forming new partnerships through the expo, reinforcing its role in China's innovation ecosystem [3] - The company aims to continue building an innovative community that benefits both China and the world [3]